{
    "2020-09-15": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Novartis' Eye Drug's Safety Label Update Approved by EMA",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Eye Drug",
                        "Safety",
                        "Label Update",
                        "EMA"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Better Buy: Veeva Systems vs. Hubspot",
                "features": {
                    "keywords": [
                        "Veeva Systems",
                        "Hubspot",
                        "Better Buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "software"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Excited About AstraZeneca's Coronavirus Vaccine, Are Investors Immune to the Bigger Picture?",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Coronavirus Vaccine",
                        "Investors",
                        "Immune",
                        "Bigger Picture"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}